Dr. Michael Scordo, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Hematological Malignancies
Studies Blood Cancers
5 reported clinical trials
12 drugs studied

Area of expertise

1Hematological Malignancies
Michael Scordo, MD has run 2 trials for Hematological Malignancies. Some of their research focus areas include:
Stage I
Stage II
Chromosome 7 abnormality positive
2Blood Cancers
Michael Scordo, MD has run 2 trials for Blood Cancers. Some of their research focus areas include:
Stage I
Stage II
Chromosome 7 abnormality positive

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center
Image of trial facility.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Michael Scordo, MD is currently running

More about Michael Scordo, MD

Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Scordo, MD has experience with
  • Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
  • Antithymocyte Globulin (ATG)
  • Busulfan
  • Fludarabine
  • Melphalan
  • Romiplostim

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Scordo, MD specialize in?
Michael Scordo, MD focuses on Hematological Malignancies and Blood Cancers. In particular, much of their work with Hematological Malignancies has involved Stage I patients, or patients who are Stage II.
Is Michael Scordo, MD currently recruiting for clinical trials?
Yes, Michael Scordo, MD is currently recruiting for 1 clinical trial in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michael Scordo, MD has studied deeply?
Yes, Michael Scordo, MD has studied treatments such as Allogeneic hematopoietic cell transplantation (Allo-HCT), Antithymocyte globulin (ATG), Busulfan.
What is the best way to schedule an appointment with Michael Scordo, MD?
Apply for one of the trials that Michael Scordo, MD is conducting.
What is the office address of Michael Scordo, MD?
The office of Michael Scordo, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security